| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chairman | Director | President
2 companies
Nash Duane is an Executive Chairman at IMUX with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $450K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2017 | AKBA Akebia Therapeutics, Inc. | Director | Sell | 1,980 | $10.46 | $20,711.00 | -7.2% | |
| Oct 3, 2016 | AKBA Akebia Therapeutics, Inc. | Director | Sell | 1,981 | $8.96 | $17,746.00 | -6.7% | |
| Jul 6, 2016 | AKBA Akebia Therapeutics, Inc. | Director | Sell | 1,980 | $7.48 | $14,818.52 | -6.3% | |
| Oct 2, 2015 | AKBA Akebia Therapeutics, Inc. | Director | Sell | 996 | $8.65 | $8,617.29 | -3.1% | |
| Jul 2, 2015 | AKBA Akebia Therapeutics, Inc. | Director | Sell | 996 | $9.53 | $9,489.89 | -3.0% | |
| Apr 2, 2015 | AKBA Akebia Therapeutics, Inc. | Director | Sell | 996 | $9.09 | $9,051.75 | -7.7% | |
| Jan 2, 2015 | AKBA Akebia Therapeutics, Inc. | Director | Sell | 995 | $11.46 | $11,403.40 | -7.2% |